Literature DB >> 14968438

Differential expression of hZnT-4 in human prostate tissues.

Frances W J Beck1, Ananda S Prasad, Charles E Butler, Wael A Sakr, Omer Kucuk, Fazlul H Sarkar.   

Abstract

BACKGROUND: Altered zinc levels in prostate benign prostatic hyperplasia (BPH) and carcinoma is well documented. It is not known whether loss of zinc, necessary to restrain aggressive growth, results from loss of a single specific or multiple zinc transporters.
METHODS: Human prostate tissues from patients who underwent radical prostatectomy were screened by RT-PCR analysis for five zinc transporters. Relative cDNA expression was determined in normal, BPH, and tumor specimens and four prostate epithelial cell lines.
RESULTS: Surgical specimens were obtained from patients with assigned Gleason scores ranging from 5 to 9. Relative expression of hZIP-1 and hZnT-1 were prominent in most samples with relatively lesser degree of expression of hZIP-2 and no detectable expression of hZnT-3. Expression of hZnT-4 was decreased in BPH and tumor samples compared to normal tissue.
CONCLUSIONS: These data suggest that zinc homeostasis in normal prostate tissues results from an interplay of multiple transporters and decreased hZnT-4 expression is associated with prostate tissue abnormalities independent of total cellular zinc content. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14968438     DOI: 10.1002/pros.10344

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  16 in total

Review 1.  Zinc and zinc transporters in normal prostate and the pathogenesis of prostate cancer.

Authors:  Renty B Franklin; Beatrice Milon; Pei Feng; Leslie C Costello
Journal:  Front Biosci       Date:  2005-09-01

2.  Regulation of zinc transporters by dietary zinc supplement in breast cancer.

Authors:  Daoxu Sun; Lianying Zhang; Yongsheng Wang; Xiaolei Wang; Xiaoyan Hu; Fu-Ai Cui; Feng Kong
Journal:  Mol Biol Rep       Date:  2007-05-01       Impact factor: 2.316

3.  Expression of the ZNT (SLC30) family members in the epithelium of the mouse prostate during sexual maturation.

Authors:  Catherine P Kirschke; Liping Huang
Journal:  J Mol Histol       Date:  2008-06-12       Impact factor: 2.611

4.  Age-related histological and zinc content changes in adult nonhyperplastic prostate glands.

Authors:  Vladimir Zaichick; Sofia Zaichick
Journal:  Age (Dordr)       Date:  2013-07-14

5.  Resveratrol-zinc combination for prostate cancer management.

Authors:  Chandra K Singh; Anna Pitschmann; Nihal Ahmad
Journal:  Cell Cycle       Date:  2014-05-27       Impact factor: 4.534

6.  Dietary zinc and prostate cancer in the TRAMP mouse model.

Authors:  Ananda S Prasad; Hasan Mukhtar; Frances W J Beck; Vaqar M Adhami; Imtiaz A Siddiqui; Maria Din; Bilal B Hafeez; Omer Kucuk
Journal:  J Med Food       Date:  2010-02       Impact factor: 2.786

7.  Marginal zinc deficiency increases oxidative DNA damage in the prostate after chronic exercise.

Authors:  Yang Song; Valerie Elias; Andrei Loban; Angus G Scrimgeour; Emily Ho
Journal:  Free Radic Biol Med       Date:  2009-10-28       Impact factor: 7.376

8.  Zinc transporter expression profiles in the rat prostate following alterations in dietary zinc.

Authors:  Yang Song; Valerie Elias; Carmen P Wong; Angus G Scrimgeour; Emily Ho
Journal:  Biometals       Date:  2009-09-17       Impact factor: 2.949

Review 9.  Zinc transporters in prostate cancer.

Authors:  M-C Franz; P Anderle; M Bürzle; Y Suzuki; M R Freeman; M A Hediger; G Kovacs
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

Review 10.  Zinc and prostatic cancer.

Authors:  Emily Ho; Yang Song
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-11       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.